• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

给予肾上腺髓质素对大鼠乙酸诱导性结肠炎的影响。

Effect of adrenomedullin administration on acetic acid-induced colitis in rats.

作者信息

Ashizuka Shinya, Ishikawa Naoto, Kato Johji, Yamaga Junichi, Inatsu Haruhiko, Eto Tanenao, Kitamura Kazuo

机构信息

First Department of Internal Medicine, Miyazaki Medical College, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.

出版信息

Peptides. 2005 Dec;26(12):2610-5. doi: 10.1016/j.peptides.2005.05.007. Epub 2005 Jun 23.

DOI:10.1016/j.peptides.2005.05.007
PMID:15978699
Abstract

Adrenomedullin (AM) administered intracolonically ameliorated the severity of acetic acid-induced colonic ulceration in rats. Ulcers were induced by subserosal injection of acetic acid into the colon. AM-treated group was administered 0.25-1.0 microg of AM in 0.5 ml of saline intracolonically once a day; the control group received only saline. AM administration dose-dependently and significantly reduced the size of the ulcerative lesions, the associated edema, and the infiltration of the affected area by inflammatory cells. AM also reduced tissue levels of interleukin-6, but not interferon-gamma. AM reduces the severity of acetic acid-induced colitis in rats, probably by inhibiting the production and/or release of Th-2 cell-derived factors such as interleukin-6.

摘要

结肠内给予肾上腺髓质素(AM)可减轻大鼠乙酸诱导的结肠溃疡严重程度。通过向结肠浆膜下注射乙酸诱导溃疡。AM治疗组每天一次结肠内给予0.5 ml盐水中含0.25 - 1.0微克的AM;对照组仅接受盐水。AM给药剂量依赖性且显著地减小了溃疡性病变的大小、相关水肿以及炎症细胞对受累区域的浸润。AM还降低了白细胞介素-6的组织水平,但未降低干扰素-γ的水平。AM可能通过抑制Th-2细胞衍生因子如白细胞介素-6的产生和/或释放来减轻大鼠乙酸诱导的结肠炎的严重程度。

相似文献

1
Effect of adrenomedullin administration on acetic acid-induced colitis in rats.给予肾上腺髓质素对大鼠乙酸诱导性结肠炎的影响。
Peptides. 2005 Dec;26(12):2610-5. doi: 10.1016/j.peptides.2005.05.007. Epub 2005 Jun 23.
2
Acute and chronic responses associated with adrenomedullin administration in experimental colitis.实验性结肠炎中与肾上腺髓质素给药相关的急性和慢性反应。
Peptides. 2008 Nov;29(11):2001-12. doi: 10.1016/j.peptides.2008.07.013. Epub 2008 Jul 29.
3
Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid.表没食子儿茶素-3-没食子酸酯可改善醋酸诱导的大鼠结肠炎。
Biomed Pharmacother. 2008 Mar;62(3):189-96. doi: 10.1016/j.biopha.2008.02.002. Epub 2008 Feb 20.
4
Protective effect of Copaifera langsdorffii oleo-resin against acetic acid-induced colitis in rats.朗氏 Copaifera 油树脂对大鼠乙酸诱导性结肠炎的保护作用。
J Ethnopharmacol. 2004 Jul;93(1):51-6. doi: 10.1016/j.jep.2004.03.028.
5
Ameliorative effect of pyrrolidinedithiocarbamate on acetic acid-induced colitis in rats.吡咯烷二硫代氨基甲酸盐对大鼠乙酸诱导性结肠炎的改善作用
Eur J Pharmacol. 2007 Jan 5;554(1):69-77. doi: 10.1016/j.ejphar.2006.09.066. Epub 2006 Oct 13.
6
Protective effect of melatonin in acetic acid induced colitis in rats.褪黑素对大鼠乙酸诱导性结肠炎的保护作用。
J Pineal Res. 2007 Apr;42(4):364-70. doi: 10.1111/j.1600-079X.2007.00428.x.
7
Protective effect of boldine in experimental colitis.去甲粉防己碱对实验性结肠炎的保护作用。
Planta Med. 1997 Aug;63(4):311-5. doi: 10.1055/s-2006-957689.
8
Adrenomedullin treatment reduces intestinal inflammation and maintains epithelial barrier function in mice administered dextran sulphate sodium.肾上腺髓质素治疗可减轻给予葡聚糖硫酸钠的小鼠的肠道炎症,并维持其上皮屏障功能。
Microbiol Immunol. 2009 Oct;53(10):573-81. doi: 10.1111/j.1348-0421.2009.00159.x.
9
Exposure to continuous darkness ameliorates gastric and colonic inflammation in the rat: both receptor and non-receptor-mediated processes.
J Gastroenterol Hepatol. 2005 Feb;20(2):294-303. doi: 10.1111/j.1440-1746.2004.03579.x.
10
Protective effect of natural honey against acetic acid-induced colitis in rats.天然蜂蜜对大鼠乙酸诱导性结肠炎的保护作用。
Trop Gastroenterol. 2002 Apr-Jun;23(2):82-7.

引用本文的文献

1
Clinical Potential of Adrenomedullin Signaling in the Cardiovascular System.心血管系统中肾上腺髓质素信号的临床潜力。
Circ Res. 2023 Apr 28;132(9):1185-1202. doi: 10.1161/CIRCRESAHA.123.321673. Epub 2023 Apr 27.
2
Adrenomedullin alleviates mucosal injury in experimental colitis and increases claudin-4 expression in the colonic epithelium.肾上腺髓质素可减轻实验性结肠炎的黏膜损伤,并增加结肠上皮细胞中紧密连接蛋白-4 的表达。
FEBS Open Bio. 2023 Apr;13(4):713-723. doi: 10.1002/2211-5463.13577. Epub 2023 Feb 27.
3
Adrenomedullin for biologic-resistant Crohn's disease: A randomized, double-blind, placebo-controlled phase 2a clinical trial.
生物治疗抵抗性克罗恩病的肾上腺髓质素:一项随机、双盲、安慰剂对照的 2a 期临床试验。
J Gastroenterol Hepatol. 2022 Nov;37(11):2051-2059. doi: 10.1111/jgh.15945. Epub 2022 Jul 25.
4
Adrenomedullin Therapy in Moderate to Severe COVID-19.肾上腺髓质素治疗中重度新型冠状病毒肺炎
Biomedicines. 2022 Feb 24;10(3):533. doi: 10.3390/biomedicines10030533.
5
Adrenomedullin: Not Just Another Gastrointestinal Peptide.肾上腺髓质素:不仅仅是另一种胃肠道肽。
Biomolecules. 2022 Jan 18;12(2):156. doi: 10.3390/biom12020156.
6
Adrenomedullin: A Novel Therapeutic for the Treatment of Inflammatory Bowel Disease.肾上腺髓质素:一种治疗炎症性肠病的新型疗法。
Biomedicines. 2021 Aug 23;9(8):1068. doi: 10.3390/biomedicines9081068.
7
Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.肿瘤学中靶向肾上腺髓质素:一种可行的策略,其潜力远不止是一种替代性抗血管生成疗法。
Front Oncol. 2021 Jan 6;10:589218. doi: 10.3389/fonc.2020.589218. eCollection 2020.
8
Safety, Tolerability, and Pharmacokinetics of Adrenomedullin in Healthy Males: A Randomized, Double-Blind, Phase 1 Clinical Trial.肾上腺髓质素在健康男性中的安全性、耐受性和药代动力学:一项随机、双盲、1期临床试验。
Drug Des Devel Ther. 2020 Jan 6;14:1-11. doi: 10.2147/DDDT.S225220. eCollection 2020.
9
Adrenomedullin: A Novel Therapy for Intractable Crohn's Disease with a Loss of Response to Infliximab.肾上腺髓质素:一种针对对英夫利昔单抗治疗无反应的难治性克罗恩病的新型疗法。
Intern Med. 2019 Jun 1;58(11):1573-1576. doi: 10.2169/internalmedicine.1791-18. Epub 2019 Feb 1.
10
Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis.肾上腺髓质素和肾上腺髓质素靶向治疗作为脓毒症相关的治疗策略。
Front Immunol. 2018 Feb 19;9:292. doi: 10.3389/fimmu.2018.00292. eCollection 2018.